Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

2026 deadlines loom as Congress leaves DC with several unfinished battles

by admin December 27, 2025
December 27, 2025
2026 deadlines loom as Congress leaves DC with several unfinished battles

Capitol Hill is a ghost town with both the House and Senate out of session until a few days into the new year.

Lawmakers left town the week before Christmas, and with their departure have left several key fights unresolved — with deadlines looming large for both Republicans and Democrats.

Government funding

Congress voted to end the longest-ever government shutdown in history last month after 43 days of gridlock.

But lawmakers did not strike a deal on federal funding for the rest of fiscal year (FY) 2026, which they’re expected to do annually. Instead, they passed a portion of FY 2026 funding while punting the deadline for the majority of areas to Jan. 30.

Senate Republicans had hoped to strike a deal on the vast majority of the remaining funds before leaving town, but various objections from senators on both sides of the aisle delayed an actual vote. 

Now, that legislation will have to be reckoned with in early January. During that month, the House and Senate will only have a total of eight days in session together before the Jan. 30 deadline.

The Senate will have 15 total days in session, while the House will have 12.

Healthcare

Millions of people across the country are expected to see an increase in how much they pay for healthcare premiums every month starting in January.

Congress, meanwhile, has failed to pass a compromise between the House and Senate to help Americans deal with the rising cost.

For some Americans on Obamacare, part of that is due to COVID-19 pandemic-era enhanced subsidies expiring at the end of 2025. 

Republicans have largely rejected the notion of extending those subsidies, at least without significant reforms. But a small group of moderate GOP lawmakers are pushing for a short-term extension to give Congress time to create a more permanent system for lowering costs.

The House passed a healthcare reform bill aimed at expanding options in the commercial insurance marketplace the week before leaving town. In the Senate, however, dueling plans by Republicans and Democrats failed to advance.

It will now be an issue for GOP congressional leaders to tackle in 2026 — while Democrats are likely to seize on it as an election-year issue.

Redistricting

Mid-decade redistricting has upended state and federal politics across the U.S. this year, with President Donald Trump pushing multiple GOP-controlled states to change their congressional lines in order to give Republicans an advantage in the 2026 midterms.

Democrat-led states like California have responded by moving to redraw their own maps to give the left an advantage. It’s resulted in prolonged court battles on both sides.

In Texas, where new maps could give Republicans as many as five new House seats, the Supreme Court granted an emergency stay on a lower court’s order allowing the GOP-led initiative to move forward.

The federal court battle over the Golden State’s new map is likely to draw into the new year. Meanwhile, states like Virginia, Illinois, Alabama, and Louisiana could still move to make new lines before next November.

Multiple House lawmakers have introduced legislation to ban mid-decade redistricting, but to no avail so far.

House Minority Leader Hakeem Jeffries, D-N.Y., warned at a press conference earlier this month, ‘Republicans may have started this redistricting battle. We as Democrats plan to finish it.’

Speaker Mike Johnson, R-La., by contrast, has taken a largely hands-off approach, preferring to leave the matter to state legislatures and the courts.

This post appeared first on FOX NEWS

previous post
Israel FM accuses Palestinian Authority of aiding terror with ‘Pay-for-Slay’ after deadly attack

Related Posts

NEWT GINGRICH: The Trump-Johnson-Thune budget victory

March 16, 2025

Rap star Nicki Minaj thanks Trump for addressing...

November 2, 2025

Biden’s EPA pushed to ‘de-gender’ agency bathrooms, hire...

March 13, 2025

Pentagon freezes out DC think tanks in new...

July 26, 2025

Hegseth to look into ‘what went wrong’ in...

February 8, 2025

DAVID MARCUS: Calling Rep. Sarah McBride ‘mister’ isn’t...

March 13, 2025

GREGG JARRETT: Comey’s Russian hoax is a reminder...

November 15, 2025

Trumps takes jab at Biden over ‘autopen signature’...

March 17, 2025

Banned chemicals found in American shampoo, sunscreen and...

August 1, 2025

FBI investigating Iran strike leaker, Leavitt says: ‘They...

June 27, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved